Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 44% ± 21% | |
lung | 8 studies | 29% ± 11% | |
eye | 6 studies | 41% ± 18% | |
peripheral blood | 4 studies | 25% ± 5% | |
heart | 4 studies | 32% ± 6% | |
breast | 3 studies | 22% ± 3% | |
intestine | 3 studies | 18% ± 1% | |
adipose | 3 studies | 41% ± 13% | |
kidney | 3 studies | 29% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 5317.03 | 459 / 459 | 100% | 14.70 | 1118 / 1118 |
esophagus | 100% | 4615.87 | 1445 / 1445 | 100% | 14.23 | 183 / 183 |
lung | 100% | 5064.40 | 578 / 578 | 100% | 12.25 | 1155 / 1155 |
ovary | 100% | 5852.58 | 180 / 180 | 100% | 10.01 | 430 / 430 |
bladder | 100% | 5131.86 | 21 / 21 | 100% | 9.55 | 503 / 504 |
prostate | 100% | 4508.26 | 245 / 245 | 100% | 10.95 | 501 / 502 |
intestine | 100% | 4777.95 | 966 / 966 | 100% | 9.15 | 525 / 527 |
uterus | 100% | 5422.26 | 170 / 170 | 100% | 10.67 | 457 / 459 |
pancreas | 100% | 2502.07 | 328 / 328 | 99% | 9.13 | 177 / 178 |
brain | 99% | 3399.96 | 2626 / 2642 | 100% | 9.93 | 705 / 705 |
thymus | 100% | 4614.94 | 653 / 653 | 99% | 10.28 | 601 / 605 |
stomach | 100% | 3422.51 | 359 / 359 | 99% | 9.77 | 284 / 286 |
kidney | 100% | 2885.94 | 89 / 89 | 98% | 8.96 | 886 / 901 |
skin | 100% | 6117.30 | 1809 / 1809 | 98% | 12.09 | 464 / 472 |
liver | 100% | 2071.28 | 226 / 226 | 97% | 5.75 | 393 / 406 |
adrenal gland | 100% | 3927.85 | 258 / 258 | 96% | 8.84 | 221 / 230 |
adipose | 100% | 5479.94 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5697.87 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.95 | 29 / 29 |
muscle | 100% | 5961.25 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3922.01 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 9.73 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.58 | 1 / 1 |
heart | 98% | 3232.09 | 841 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 2978.39 | 894 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 90% | 7.12 | 72 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0039585 | Biological process | PKR/eIFalpha signaling |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0031464 | Cellular component | Cul4A-RING E3 ubiquitin ligase complex |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031463 | Cellular component | Cul3-RING ubiquitin ligase complex |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_0031462 | Cellular component | Cul2-RING ubiquitin ligase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0015030 | Cellular component | Cajal body |
GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
GO_0097413 | Cellular component | Lewy body |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0019787 | Molecular function | ubiquitin-like protein transferase activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0031624 | Molecular function | ubiquitin conjugating enzyme binding |
Gene name | ARIH1 |
Protein name | Ariadne RBR E3 ubiquitin protein ligase 1 E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.31) (H7-AP2) (HHARI) (Monocyte protein 6) (MOP-6) (Protein ariadne-1 homolog) (ARI-1) (UbcH7-binding protein) (UbcM4-interacting protein) (Ubiquitin-conjugating enzyme E2-binding protein 1) RBR-type E3 ubiquitin transferase (EC 2.3.2.31) |
Synonyms | MOP6 ARI UBCH7BP HUSSY-27 |
Description | FUNCTION: E3 ubiquitin-protein ligase, which catalyzes ubiquitination of target proteins together with ubiquitin-conjugating enzyme E2 UBE2L3 . Acts as an atypical E3 ubiquitin-protein ligase by working together with cullin-RING ubiquitin ligase (CRL) complexes and initiating ubiquitination of CRL substrates: associates with CRL complexes and specifically mediates addition of the first ubiquitin on CRLs targets . The initial ubiquitin is then elongated by CDC34/UBE2R1 and UBE2R2 . E3 ubiquitin-protein ligase activity is activated upon binding to neddylated cullin-RING ubiquitin ligase complexes . Plays a role in protein translation in response to DNA damage by mediating ubiquitination of EIF4E2, the consequences of EIF4E2 ubiquitination are however unclear . According to a report, EIF4E2 ubiquitination leads to promote EIF4E2 cap-binding and protein translation arrest . According to another report EIF4E2 ubiquitination leads to its subsequent degradation . Acts as the ligase involved in ISGylation of EIF4E2 . In vitro, controls the degradation of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex member SUN2 and may therefore have a role in the formation and localization of the LINC complex, and as a consequence, nuclear subcellular localization and nuclear morphology . . |
Accessions | ENST00000561770.1 H3BUS0 ENST00000562891.2 H3BNB9 ENST00000379887.9 Q9Y4X5 A0A087WT96 ENST00000564062.1 H3BSK4 ENST00000570085.5 |